Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07454187

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital Of Soochow University Suzhou, Jiangsu, China
  • The Second Affiliated Hospital Of Xi an Jiaotong University (Xibei Hospital) Xi’an, Shanxi, China
  • The Second Affiliated Hospital Zhejiang University School Of Medicine Hangzhou, Zhejiang, China
View Trial Details
Recruiting

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

NCT05327894

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Hospital de Pediatría S.A.M.I.C. "Juan P. Garrahan" Buenos Aires, Argentina
  • Australian and New Zealand Children's Haematology/Oncology Group Clayton, Victoria, Australia
  • North Adelaide- Womens and Childrens Hospital Adelaide, Australia
  • Monash Children's Hosptial Clayton, Australia
View all 124 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

NCT05714839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site Bullhead City, Arizona, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
View all 36 locations
View Trial Details
Recruiting

CAR-T Cell Therapy for ALL

NCT07695012

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • National University of Medical Sciences, Clinical Trial Unit Rawalpindi, Pakistan
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Minnesota Medical Center Minneapolis, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 28 locations
View Trial Details
Recruiting

A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

NCT06508983

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
View Trial Details
Recruiting

Genomic Profiling in Cancer Patients

NCT01775072

Conditions
Hematologic Cancers, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations
  • St. Vincent (Data Collection Only) Bridgeport, Connecticut, United States
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Baptist Alliance MCI Miami, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT06506084

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • SC Ematologia, ASST Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Divisione Ematologia ASST, Grande Ospedale Metropolitano Niguarda Milan, Lombardy, Italy
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
  • U.O. Ematologia, Ospedale di Circolo e Fondazione Macchi Varese Varese, Lombardy, Italy
View all 37 locations
View Trial Details

Related conditions